Transcutaneous Electrical Nerve Stimulation for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Transcutaneous Electrical Nerve Stimulation for Health & Longevity

Created on 10/03/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Transcutaneous electrical nerve stimulation is a low-cost, drug-free device that sends mild electrical pulses through skin pads to dampen pain. Its clearest value is reliable pain relief while the unit runs, which can ease movement, exercise and recovery after surgery. Effects on mood, sleep and inflammation remain unconfirmed, and no study has examined lifespan or ageing. Risks are mostly minor; the most important hazard concerns people with implanted heart devices. (Full Review)

Protocol

Conventional high-frequency stimulation
25–150 Hz
Strong, non-painful intensity near the painful area; raised during the session as the sensation fades
Mixed-frequency movement protocol
2–125 Hz modulated, 2 hours daily
100–180 microsecond pulses, strong but comfortable intensity, during activity; pads on upper and lower back
Single versus split sessions
About 2 hours daily or 20–60 minute sessions
2 hours during activity; split sessions suit intermittent activity
Time to effect
Pain relief
Within minutes
Peaks during stimulation; can outlast it by over 30 minutes
Early response
First 30-minute session
A drop in pain or fatigue predicts later response
Fibromyalgia
Over 4 weeks
Benefit grew with daily use; sustained for 6 months with mixed frequencies

Benefits

Contraindications
  • People with implantable cardioverter-defibrillators, unless stimulation is tested under supervision of a cardiac device specialist
  • People with pacemakers, unless extended cardiac monitoring confirms no interference (bilateral placement in particular)
  • People with epilepsy, for head or neck placement (theoretical)
  • Pregnant people, for abdominal or pelvic placement outside labour (theoretical)
  • Anyone, for placement over the front of the neck (carotid sinus) or across the chest
  • People unable to feel or report stimulation (numb skin, advanced dementia) without supervision (theoretical)
    •
Key Interactions
  • Opioid analgesics (tramadol, oxycodone, morphine): Monitor
  • Opioid-blocking drugs (naloxone, naltrexone including low-dose naltrexone): Caution
  • Over-the-counter analgesics (ibuprofen, naproxen, acetaminophen): Monitor (theoretical, additive)
  • Topical anaesthetics (lidocaine patches, benzocaine creams): Avoid under electrodes (theoretical)
  • Topical counterirritants (skin rubs that create warming or cooling sensations; menthol, capsaicin, methyl salicylate): Avoid under electrodes (theoretical)
  • Supplements (palmitoylethanolamide, curcumin, omega-3 fatty acids): Monitor (theoretical, additive)
  • Other implanted stimulators (spinal cord, deep brain, sacral nerve stimulators, insulin pumps): Caution (theoretical)
  • Heat packs and heating pads: Caution (theoretical)
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Interference with implanted cardiac defibrillators and pacemakers; skin irritation under electrodes; discomfort or pain from the stimulation; waning effect with repeated daily use; burns on numb or damaged skin
    •
  • Speculative: Seizure provocation with head or neck placement; low blood pressure from front-of-neck placement; heart rhythm disturbance from across-the-chest placement; masking of undiagnosed pain; effects of abdominal use in early pregnancy
    •

Monitoring

Marker Target Why
Movement-evoked pain rating (0–10) No established target; track change from own baseline; a ≥30% fall marks response Core benefit; rated during stimulation in a set task
Cardiac device interrogation during test stimulation No established target; confirm no sensed interference Safety check; interference stops or changes use
Interleukin-6 Below 6.4 pg/mL; varies by laboratory Marker expected to change (speculative)

Cadence: Baseline before starting; then during the first 30-minute session, at 4 weeks and every 3 months. Supervised cardiac device test before any home use in people with implanted defibrillators or pacemakers.

Qualitative Assessment

  • Pain during everyday movements such as walking, stairs and lifting
  • Fatigue during and after activity
  • Ability to complete exercise sessions or daily tasks without stopping
  • Sleep quality and night-time waking from pain
  • Weekly use of pain medicines
  • Overall impression of change since starting
  • Skin condition at electrode sites
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.